April 10, 2015

New Preclinical Data on Tumor Treating Fields to be presented at the American Association for Cancer Research Annual Meeting 2015

AACR Annual Meeting 2015 April 10, 2015 08:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, announced today that four preclinical abstracts will be presented at the American Association for Cancer Research (AACR) Annual Meeting… Read More
learn more
April 10, 2015

New Preclinical Data on Tumor Treating Fields to be presented at the American Association for Cancer Research Annual Meeting 2015

AACR Annual Meeting 2015 April 10, 2015 08:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, announced today that four preclinical abstracts will be presented at the American Association for Cancer Research (AACR) Annual Meeting… Read More
learn more
April 10, 2015

New Preclinical Data on Tumor Treating Fields to be presented at the American Association for Cancer Research Annual Meeting 2015

AACR Annual Meeting 2015 April 10, 2015 08:00 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure, a commercial stage oncology company, announced today that four preclinical abstracts will be presented at the American Association for Cancer Research (AACR) Annual Meeting… Read More
learn more
April 9, 2015

Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors

April 09, 2015 07:35 PM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Kieran T. Read More
learn more
April 9, 2015

Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors

April 09, 2015 07:35 PM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Kieran T. Read More
learn more
April 9, 2015

Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors

April 09, 2015 07:35 PM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Kieran T. Read More
learn more